Search Tag: Aprecia
2015 10 Aug
The U.S. Food and Drug Administration has approved the first 3D-printed drug, SPRITAM ® , for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalised tonic-clonic seizures in adults and children with epilepsy. The FDA approval is being hailed as a breakthrough in precision...Read more